DK3194408T3 - Tetrahydropyrrolo[3,4-d][1,3]thiazin-derivat som bace-inhibitor - Google Patents

Tetrahydropyrrolo[3,4-d][1,3]thiazin-derivat som bace-inhibitor Download PDF

Info

Publication number
DK3194408T3
DK3194408T3 DK15763800.8T DK15763800T DK3194408T3 DK 3194408 T3 DK3194408 T3 DK 3194408T3 DK 15763800 T DK15763800 T DK 15763800T DK 3194408 T3 DK3194408 T3 DK 3194408T3
Authority
DK
Denmark
Prior art keywords
tetrahydropyrrolo
thiazin
derivative
bace inhibitor
bace
Prior art date
Application number
DK15763800.8T
Other languages
English (en)
Inventor
David Andrew Coates
Pablo Garcia Losada
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51688001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3194408(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK3194408T3 publication Critical patent/DK3194408T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Soil Working Implements (AREA)
DK15763800.8T 2014-09-15 2015-09-08 Tetrahydropyrrolo[3,4-d][1,3]thiazin-derivat som bace-inhibitor DK3194408T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382347 2014-09-15
PCT/US2015/048788 WO2016043996A1 (en) 2014-09-15 2015-09-08 A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor

Publications (1)

Publication Number Publication Date
DK3194408T3 true DK3194408T3 (da) 2019-07-15

Family

ID=51688001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15763800.8T DK3194408T3 (da) 2014-09-15 2015-09-08 Tetrahydropyrrolo[3,4-d][1,3]thiazin-derivat som bace-inhibitor

Country Status (40)

Country Link
US (1) US9828390B2 (da)
EP (1) EP3194408B1 (da)
JP (1) JP6353977B2 (da)
KR (1) KR101915419B1 (da)
CN (1) CN106661054B (da)
AP (1) AP2017009781A0 (da)
AR (1) AR101739A1 (da)
AU (1) AU2015318256B2 (da)
BR (1) BR112017002586A2 (da)
CA (1) CA2957043A1 (da)
CL (1) CL2017000565A1 (da)
CO (1) CO2017001927A2 (da)
CR (1) CR20170058A (da)
CY (1) CY1121709T1 (da)
DK (1) DK3194408T3 (da)
DO (1) DOP2017000070A (da)
EA (1) EA201790238A1 (da)
EC (1) ECSP17015682A (da)
ES (1) ES2733326T3 (da)
HR (1) HRP20190961T1 (da)
HU (1) HUE044386T2 (da)
IL (1) IL250350A0 (da)
LT (1) LT3194408T (da)
MA (1) MA39432B1 (da)
MX (1) MX2017003415A (da)
NZ (1) NZ728660A (da)
PE (1) PE20170674A1 (da)
PH (1) PH12017500492A1 (da)
PL (1) PL3194408T3 (da)
PT (1) PT3194408T (da)
RS (1) RS58756B1 (da)
SG (1) SG11201701637YA (da)
SI (1) SI3194408T1 (da)
SV (1) SV2017005392A (da)
TN (1) TN2017000065A1 (da)
TR (1) TR201908358T4 (da)
TW (1) TWI570127B (da)
UA (1) UA119987C2 (da)
WO (1) WO2016043996A1 (da)
ZA (1) ZA201700823B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI574969B (zh) * 2015-01-30 2017-03-21 美國禮來大藥廠 甲苯磺酸鹽
TWI735600B (zh) 2016-07-01 2021-08-11 美商美國禮來大藥廠 抗－N3pGlu類澱粉β肽抗體及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0906962B8 (pt) * 2008-01-18 2021-05-25 Eisai R&D Man Co Ltd composto de aminodiidrotiazina fundido
GB201101139D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
JO3143B1 (ar) * 2012-04-03 2017-09-20 Lilly Co Eli مركبات تتراهيدرو بيرولو ثيازين
TWI593692B (zh) * 2013-03-12 2017-08-01 美國禮來大藥廠 四氫吡咯并噻嗪化合物

Also Published As

Publication number Publication date
EA201790238A1 (ru) 2017-07-31
JP6353977B2 (ja) 2018-07-04
US9828390B2 (en) 2017-11-28
ZA201700823B (en) 2018-12-19
AP2017009781A0 (en) 2017-03-31
HRP20190961T1 (hr) 2019-07-26
PE20170674A1 (es) 2017-05-22
BR112017002586A2 (pt) 2017-12-19
MA39432B1 (fr) 2019-07-31
TWI570127B (zh) 2017-02-11
CA2957043A1 (en) 2016-03-24
EP3194408A1 (en) 2017-07-26
EP3194408B1 (en) 2019-04-17
MA39432A (fr) 2017-07-26
SV2017005392A (es) 2018-11-01
IL250350A0 (en) 2017-03-30
TN2017000065A1 (en) 2018-07-04
CR20170058A (es) 2017-04-25
JP2017530957A (ja) 2017-10-19
ES2733326T3 (es) 2019-11-28
CN106661054A (zh) 2017-05-10
CO2017001927A2 (es) 2017-07-28
HUE044386T2 (hu) 2019-10-28
AU2015318256A1 (en) 2017-02-23
SG11201701637YA (en) 2017-04-27
SI3194408T1 (sl) 2019-06-28
KR20170042678A (ko) 2017-04-19
KR101915419B1 (ko) 2018-11-05
MX2017003415A (es) 2017-06-19
AU2015318256B2 (en) 2017-12-21
PT3194408T (pt) 2019-07-12
PH12017500492A1 (en) 2017-08-07
TR201908358T4 (tr) 2019-06-21
ECSP17015682A (es) 2018-03-31
PL3194408T3 (pl) 2019-09-30
DOP2017000070A (es) 2017-04-16
LT3194408T (lt) 2019-06-10
RS58756B1 (sr) 2019-06-28
WO2016043996A1 (en) 2016-03-24
CY1121709T1 (el) 2020-07-31
AR101739A1 (es) 2017-01-11
TW201620918A (zh) 2016-06-16
CL2017000565A1 (es) 2017-11-10
UA119987C2 (uk) 2019-09-10
US20170233410A1 (en) 2017-08-17
NZ728660A (en) 2018-06-29
CN106661054B (zh) 2019-09-10

Similar Documents

Publication Publication Date Title
IL259406B (en) Heterocyclic compounds as immunomodulators
IL259169A (en) Novel pyrazolo pyrimidine derivatives
DK3322706T3 (da) Substituerede pyrazolo[1,5-a]pyridin-forbindelser som ret-kinaseinhibitorer
DK3381918T3 (da) 7-(Thiazol-5-yl)-pyrrolopyrimidinforbindelse som TLR7-agonist
DK3303348T3 (da) Naphthyridinforbindelser som JAK-kinaseinhibitorer
DK3190113T3 (da) Pyrrolopyrimidinforbindelser anvendt som tlr7-agonist
PL3209656T3 (pl) Związki indolo-karboksyamidu użyteczne jako inhibitory kinazy
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3134413T3 (da) Substituerede [1,2,4]triazolo[1,5-a]pyrimidin-7-yl-forbindelser som pde2-inhibitorer
EP3161673A4 (en) Understanding tables for search
DK3357919T3 (da) Aromatiske heterocykliske forbindelser som antiinflammatoriske forbindelser
CL2016002461A1 (es) Derivados macrocíclicos de pirimidina
MA41898A (fr) Dérivés de quinazolinone bicyclique
DK3227297T3 (da) 4,6-substitueret-pyrazolo[1,5-a]pyraziner som janus kinase-inhibitorer
PL3359543T3 (pl) Pochodne kukurbiturylu
MA41790A (fr) Dérivé de morphinane
IL260536B (en) 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
EP3346592A4 (en) Rotating machine
DK3792251T3 (da) Hidtil ukendte sulfonylaminobenzamidforbindelser som anthelmintika
IL252866A0 (en) History of imidazopyridazine as pi3kbeta inhibitors
DK3233839T3 (da) Heterocyclylkoblede imidazopyridazinderivater som pi3k-beta-inhibitorer
LT3286193T (lt) Indolo dariniai
MA41641A (fr) Dérivés de tétrahydropyranylbenzamide
DK3148976T3 (da) Fremgangsmåde til fremstilling af dihydroisoxazolderivater
ZA201700823B (en) A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor